This page lists the SEC filings reported by Meditor Group Ltd.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-01-03 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 3,791,300 | 3.3% | EDGAR |
| SC 13G/A | 2023-01-04 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 4,468,835 | 6.1% | EDGAR |
| SC 13G/A | 2022-01-12 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 4,468,835 | 7.1% | EDGAR |
| SC 13G/A | 2021-01-06 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 2,679,835 | 9.6% | EDGAR |
| SC 13G/A | 2020-01-03 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 2,679,835 | 9.9% | EDGAR |
| SC 13G/A | 2019-04-09 | Meditor Group Ltd | EXELIXIS, INC. | 15,001,073 | 5.0% | EDGAR |
| SC 13G/A | 2019-01-03 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 2,679,835 | 9.9% | EDGAR |
| SC 13G/A | 2019-01-02 | Meditor Group Ltd | EXELIXIS, INC. | 15,966,038 | 5.3% | EDGAR |
| SC 13G/A | 2018-01-04 | Meditor Group Ltd | EXELIXIS, INC. | 16,484,638 | 5.6% | EDGAR |
| SC 13G/A | 2018-01-03 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 2,322,835 | 8.9% | EDGAR |
| SC 13G | 2017-08-21 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 2,103,200 | 8.2% | EDGAR |
| SC 13G/A | 2017-02-01 | Meditor Group Ltd | EXELIXIS, INC. | 21,509,713 | 7.5% | EDGAR |
| SC 13G/A | 2016-01-25 | Meditor Group Ltd | EXELIXIS, INC. | 22,070,213 | 9.7% | EDGAR |
| SC 13G/A | 2015-02-09 | Meditor Group Ltd | EXELIXIS, INC. | 19,070,213 | 9.7% | EDGAR |
| SC 13G/A | 2014-01-21 | Meditor Group Ltd | EXELIXIS, INC. | 10,533,384 | 5.7% | EDGAR |
| SC 13G/A | 2013-01-25 | Meditor Group Ltd | EXELIXIS, INC. | 12,000,000 | 6.5% | EDGAR |
| SC 13G/A | 2012-12-19 | Meditor Group Ltd | VIVUS INC | 5,002,896 | 5.0% | EDGAR |
| SC 13G | 2012-08-20 | Meditor Group Ltd | EXELIXIS INC | 9,500,000 | 5.3% | EDGAR |
| SC 13G/A | 2012-08-17 | Meditor Group Ltd | VIVUS INC | 5,081,600 | 5.1% | EDGAR |
| SC 13G/A | 2012-07-26 | Meditor Group Ltd | VIVUS INC | 5,803,600 | 5.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.